See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2013

Biologic Therapy For Claudication FIM Strategy

Presenter: Todd J. Brinton

January 22, 2013

Presentation Cell Therapy 2013

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

Presenter: Stephen G. Ellis

January 22, 2013

Presentation Cell Therapy 2013

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Presentation Cell Therapy 2013

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Presenter: Frank J. Giordano

January 22, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation Cell Therapy 2013

MPC's for Ischemic and Nonischemic Heart Failure

Presenter: Emerson C. Perin

January 22, 2013

Presentation Cell Therapy 2013

NOGA-Guided CD133+ Cells for CMI

Presenter: Wojciech Wojakowski

January 22, 2013

Presentation Cell Therapy 2013

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

Presenter: Marc S. Penn

January 22, 2013

Presentation Cell Therapy 2013

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Presenter: Emerson C.Perin

January 22, 2013

Advertisement

Slides

Biologic Therapy For Claudication FIM Strategy

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

CD-34+ Cells for Ischemic Heart Failure

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

MPC's for Ischemic and Nonischemic Heart Failure

NOGA-Guided CD133+ Cells for CMI

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content